🏢 官网IRPRGOCodex · 实盘不做把握 9/10
北京时间·🕒 发布 20:30:00时区推断·⟳ 抓取 20:35:49·⚡ 决策 07-22 20:37:33 +1m44s·97.0 天前
Perrigo公布二季度业绩发布时间和电话会安排
本次仅为Perrigo（PRGO.US）提前通知2026年8月5日发布二季度财报及召开电话会，未披露收入、利润、指引或经营超预期信息。
📄 原文PRGO↗ 原文
Perrigo to Release Second Quarter 2026 Financial Results on August 5, 2026
DUBLIN, July 22, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of consumer self-care produc…
不做 Perrigo（PRGO.US）
仅为财报发布时间和电话会安排公告，没有业绩数据、指引修正或可量化经营增量，方向中性不做。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
🔎 新鲜度:最早出现 2026-07-22 · 扩散 low · price-in 风险 low ↗
关键理由
- 本次仅为Perrigo（PRGO.US）提前通知2026年8月5日发布二季度财报及召开电话会，未披露收入、利润、指引或经营超预期信息。
主要风险
- 真正可交易的信息需等待8月5日财报数据和管理层指引，当前日程公告本身没有方向。
原文全文
展开原文 · 2,910 字
DUBLIN, July 22, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of consumer self-care products, today announced that it plans to release its second quarter 2026 financial results on Wednesday, August 5th, 2026. The company will hold a conference call beginning at 8:30 a.m. (EST) hosted by Interim President and CEO Albert Manzone and CFO Eduardo Bezerra.
The earnings conference call will be available live via webcast in the investor relations section of the Perrigo website at http://perrigo.investorroom.com/events-webcasts or by phone at 800-836-8184, U.S., 646-357-8785, International, and conference ID 98476. A replay of the call will be available beginning at approximately 12:00 p.m. (EST) Wednesday, August 5, through Wednesday, August 12, 2026. To access the replay, dial 888-660-6345, U.S., 646-517-4150, International, and enter access code 98476 #.
About Perrigo
Perrigo Company plc is a leading pure-play self-care company with over a century of experience in providing high-quality health and wellness solutions to consumers primarily in North America and Europe. As a pioneer in the over-the-counter (OTC) self-care market, Perrigo offers trusted self-care solutions that can be used without the need for a prescription, ensuring accessibility and choice for consumers across molecules, dosage forms, and value tiers.
Perrigo's unique business model leverages its complementary businesses, where cash-generative store brand private label offerings fuel investments for leading brands, including Opill®, Mederma®, Compeed®, EllaOne®, and Jungle Formula®.
For more information, visit www.perrigo.com.
Forward-Looking Statements
This press release includes, and the matters discussed in Perrigo's upcoming earnings release will include certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements involve known and unknown risks, uncertainties and other factors—many of which are beyond the Company's control—that may cause the actual results, performance or achievements of the Company to be materially different from its current expectations, assumptions, estimates and projections. Interested persons are urged to consult the Company's filings with the United States Securities and Exchange Commission, available at https://investor.perrigo.com/sec-filings, for a discussion of the Company's business and financial condition and certain material trends, risks, uncertainties and other factors relating thereto, including those discussed under "Risk Factors" in the Company's Form 10-K for the year ended December 31, 2025.
Perrigo Contacts
Eric Jacobson, Vice President, Global Investor Relations
(616) 886-0375, eric.jacobson@perrigo.com
Nick Gallagher, Associate Director, Global Investor Relations
(269) 686-3238, nicholas.gallagher@perrigo.com
SOURCE Perrigo Company plc
The earnings conference call will be available live via webcast in the investor relations section of the Perrigo website at http://perrigo.investorroom.com/events-webcasts or by phone at 800-836-8184, U.S., 646-357-8785, International, and conference ID 98476. A replay of the call will be available beginning at approximately 12:00 p.m. (EST) Wednesday, August 5, through Wednesday, August 12, 2026. To access the replay, dial 888-660-6345, U.S., 646-517-4150, International, and enter access code 98476 #.
About Perrigo
Perrigo Company plc is a leading pure-play self-care company with over a century of experience in providing high-quality health and wellness solutions to consumers primarily in North America and Europe. As a pioneer in the over-the-counter (OTC) self-care market, Perrigo offers trusted self-care solutions that can be used without the need for a prescription, ensuring accessibility and choice for consumers across molecules, dosage forms, and value tiers.
Perrigo's unique business model leverages its complementary businesses, where cash-generative store brand private label offerings fuel investments for leading brands, including Opill®, Mederma®, Compeed®, EllaOne®, and Jungle Formula®.
For more information, visit www.perrigo.com.
Forward-Looking Statements
This press release includes, and the matters discussed in Perrigo's upcoming earnings release will include certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements involve known and unknown risks, uncertainties and other factors—many of which are beyond the Company's control—that may cause the actual results, performance or achievements of the Company to be materially different from its current expectations, assumptions, estimates and projections. Interested persons are urged to consult the Company's filings with the United States Securities and Exchange Commission, available at https://investor.perrigo.com/sec-filings, for a discussion of the Company's business and financial condition and certain material trends, risks, uncertainties and other factors relating thereto, including those discussed under "Risk Factors" in the Company's Form 10-K for the year ended December 31, 2025.
Perrigo Contacts
Eric Jacobson, Vice President, Global Investor Relations
(616) 886-0375, eric.jacobson@perrigo.com
Nick Gallagher, Associate Director, Global Investor Relations
(269) 686-3238, nicholas.gallagher@perrigo.com
SOURCE Perrigo Company plc
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。